These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2402318)

  • 1. Can a dietitian help prevent renal bone disease in the hemodialysis patient?
    Harum P
    Nephrol News Issues; 1990 Sep; 4(9):35, 37, 42. PubMed ID: 2402318
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone disease in patients with chronic renal failure and during long-term hemodialysis].
    Flury W
    Ther Umsch; 1972 Sep; 29(9):554-9. PubMed ID: 4628712
    [No Abstract]   [Full Text] [Related]  

  • 4. [The course of osteodystrophy in patients with chronic kidney failure on hemodialysis].
    Zemchenko AIu; Shostka GD
    Urol Nefrol (Mosk); 1993; (6):51-4. PubMed ID: 8160326
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E; Craver L
    Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
    Besarab A; Caro JF; Ihle BU; Burke JF; Glennon JA; Fischer JA
    Nephron; 1981; 27(3):127-33. PubMed ID: 7219643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal osteodystrophy--more than a mere bone disease].
    Saha H
    Duodecim; 2001; 117(21):2181-7. PubMed ID: 12184205
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
    Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
    Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
    [No Abstract]   [Full Text] [Related]  

  • 9. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic indications obtained from short- and medium-term biohumoral changes after parathyroidectomy].
    Sforzini S; Viganò MR; Rosa M; Redaelli B
    Minerva Med; 1985 Mar; 76(9-10):393-6. PubMed ID: 3982696
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing bone disease requires diligent management in patients with renal failure.
    Kolb FO
    West J Med; 1994 May; 160(5):475-7. PubMed ID: 8048242
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical management of renal hyperparathyroidism. Pulse treatment with vitamin D metabolites or not?
    Reichel H
    Nephrol Dial Transplant; 1994; 9(10):1368-70. PubMed ID: 7816246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
    Goto S; Fukagawa M
    Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for parathyroidectomy in patients with chronic renal failure.
    Finch T; Jacobs JK
    Am Surg; 1974 Jan; 40(1):40-4. PubMed ID: 4808621
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study on the disturbances in calcium and bone disease: renal osteodystrophy in patients with chronic renal failure].
    Yoshidome E
    Igaku Kenkyu; 1987 May; 57(2):83-104. PubMed ID: 3673482
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperparathyroidism in the maintenance dialysis patient.
    Glassford DM; Remmers AR; Sarles HE; Lindley JD; Scurry MT; Fish JC
    Surg Gynecol Obstet; 1976 Mar; 142(3):328-32. PubMed ID: 1251311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of surgical methods in the treatment of renal osteodystrophy. Personal cases and remote results].
    Borrelli D; Cicchi P; Burci P; Perigli G; Bandini S; Solfanelli E
    Minerva Med; 1985 Mar; 76(9-10):429-39. PubMed ID: 3982701
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteomalacia associated with aluminum intoxication in a patient with chronic renal failure.
    Bauer TW; Popowniak KL; Stulberg BN; McMahon JT
    Cleve Clin Q; 1985; 52(2):271-8. PubMed ID: 4028429
    [No Abstract]   [Full Text] [Related]  

  • 19. [Letter to the authors of the "Recommendations for clinical practice" concerning the prevention of renal osteodystrophy before extra-renal purification].
    Fournier A; Aparicio M
    Nephrologie; 1998; 19(3):129-30. PubMed ID: 9633056
    [No Abstract]   [Full Text] [Related]  

  • 20. The shrinking man. A manifestation of severe renal osteodystrophy.
    Horensten ML; Boner G; Rosenfeld JB
    JAMA; 1980 Jul; 244(3):267-8. PubMed ID: 7382093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.